GW Pharmaceuticals
Privately held: no public share price
Assets
(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | GPR55 / TRPV1 / adenosine transport (multi-target) · cannabinoidSmall molecule | EpilepsyDevelopmental and Epileptic EncephalopathiesDravet SyndromeLennox-Gastaut Syndrome |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.